window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-EE4YC2THRT');
Accessibility
-A: Font Smaller
+A: Font Larger
Reset Font
High Contrast
Low Contrast
Reset Contrast
About
News
Events
Community
RAAM Clinics
Resource Library
Toolkits
About
News
Events
Community
RAAM Clinics
Resource Library
Toolkits
Accessibility
Accessibility
-A: Font Smaller
+A: Font Larger
Reset Font
High Contrast
Low Contrast
Reset Contrast
×
Opioid Agonist Therapy Decision Aid Tool
Home
/
Pharmacotherapy
/
Page 2
Slow-release oral morphine as opioid agonist therapy: Plain language summary
Home
/
Pharmacotherapy
/
Page 2
Recommendations For Use of Slow-Release Oral Morphine as Opioid Agonist Therapy
Home
/
Pharmacotherapy
/
Page 2
New Guidelines for the Use of Slow-Release Oral Morphine as Opioid Agonist Therapy
Home
/
Pharmacotherapy
/
Page 2
Barriers and Facilitators to Implementing ED-initiated Buprenorphine
Home
/
Pharmacotherapy
/
Page 2
Benzodiazepines and Benzodiazepine Use Disorder
Home
/
Pharmacotherapy
/
Page 2
Elective Admission for Management of Alcohol Withdrawal in a Short-Stay Medicine Unit in Toronto
Home
/
Pharmacotherapy
/
Page 2
Managing Psychosis in Addictions Clinics: Substance-Induced and Beyond
Home
/
Pharmacotherapy
/
Page 2
The West Parry Sound Health Centre Mental Health Hub
Home
/
Pharmacotherapy
/
Page 2
A Summary of Evidence to Optimize the Use of Extended-Release Buprenorphine in Opioid Use Disorder
Home
/
Pharmacotherapy
/
Page 2
